CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Cranberry juice +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05260346
NCT05260346N/ACompleted

Modulation of the Gut-brain Axis by Cranberries: Impact on University Students' Mental Wellbeing

King's College London·interventional·Posted Mar 2, 2022·Updated Nov 22, 2022

In Brief

A clinical study evaluating Cranberry juice and Placebo for Healthy. Completed, enrolled 64 participants across 1 site.

Detailed Summary

In this work, the investigators will assess whether cranberry (poly)phenols improve mood disorders including stress, anxiety and depression via the gut-brain axis in university students. The investigators will evaluate whether the effects observed are related to an improvement in gut microbiome diversity and function, and whether the mechanism of action may be mediated by a decrease in inflammatory markers, modulation of neurotransmitters or via an alteration of BDNF levels. The investigators will also quantify the most comprehensive panel of cranberry (poly)phenol metabolites. A double-blind, randomized placebo controlled 2-arm parallel study will be conducted in the Metabolic Research Unit (MRU, Department of Nutritional Sciences at KCL).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 2, 2022
Enrollment StartJan 10, 2022
Primary CompletionAug 22, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.3 years ago

Interventions

Cranberry juicedietary

composition: Water, cranberry juice concentrate

Placebodietary

composition: Water, dextrose, citric acid, malic acid, fumaric acid, colorants, xanthan gum, natural flavor, emulsion